Yulia Aspinall Merger Mania in Biopharma: Will Information Professionals be Victims, Witnesses or Winners?
Jinfo Article

20th December 2013 Sign in to MyJinfo or create an account be able to star items Subscribe via RSS to get updates as soon as Subscription Articles are added Tweet about this item on Twitter Share on Facebook Share on LinkedIn

By Yulia Aspinall

Abstract

With biopharmaceutical companies under pressure to maintain revenues and suffering from the upcoming expiry of key patents, more mergers and acquisitions are likely to take place. Yulia Aspinall examines how information professionals can put their skills to good use to change the challenge of possible redundancy into an opportunity, where the information services team emerges stronger post M&A.

Content Access

Access to Jinfo articles and reports is a benefit of a Jinfo Subscription.

Does your organisation have a Jinfo Subscription?
"Yes, we subscribe"

Please sign in here so that we can check your access to this item:

MyJinfo Login

Email:

Password:

  Forgotten password?

If this item has been shared with you by a colleague, please request a MyJinfo account.

"Not yet"

Gain access to this article with a Jinfo Subscription. It will help your organisation:

  1. Save time and money
  2. Re-invent information services
  3. Define, measure and communicate information value

Benefits and Pricing

Jinfo Testimonials
Testimonials


"Don't know"

Submit the Subscription Question form to find out if someone in your organisation already has a subscription or to discuss your questions or requirements.

Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.

Claire Laybats, Head of Commercial Development

Claire Laybats
Head of Commercial Development
claire.laybats@jinfo.com



Back to top ^


 « All Articles